6-month Clinical Investigation Assessing the Efficacy of an Antimicrobial Mouthrinse in Reducing Established Plaque and Improving Gum Health
← catalyst calendarNCT07414173 · readout ≤ 42 d
Sponsored by Colgate Palmolive (industry) · CL — their whole pipeline →.
Phase
Phase 4
Status
Recruiting
Study type
Interventional
Design
Randomized · Quadruple · Prevention
Enrollment
90estimated
Sites
1
Country
Germany
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2026-01-28 | actual | When the study began enrolling |
| Primary completion | Sep 2026 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Nov 2026 | estimated | The whole study's end, after follow-up |
| First posted | 2026-02-17 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-02-17 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Gingivitis
- Dental Plaque Accumulation
Interventions
- Other: Test Mouthrinse
- Other: Control Mouthrinse
Primary outcome
what the primary-completion date above is the date OFImprovement of gum health as measured by the Gingival Index (Löe 1967) between the study groups.
measured 6-month period
Permalink · CL's whole pipeline · Catalyst calendar · Every registered study · What changed